AAAAAA

   
Results: 1-16 |
Results: 16
THE EFFECT OF DEHYDROEPIANDROSTERONE COMBINED WITH A LOW-FAT DIET IN SPONTANEOUSLY OBESE DOGS - A CLINICAL-TRIAL
Authors: KURZMAN ID PANCIERA DL MILLER JB MACEWEN EG
Citation: Id. Kurzman et al., THE EFFECT OF DEHYDROEPIANDROSTERONE COMBINED WITH A LOW-FAT DIET IN SPONTANEOUSLY OBESE DOGS - A CLINICAL-TRIAL, Obesity research, 6(1), 1998, pp. 20-28
IMMUNOHISTOCHEMICAL DETECTION OF P53 TUMOR-SUPPRESSOR GENE PROTEIN INCANINE EPITHELIAL COLORECTAL TUMORS
Authors: WOLF JC GINN PE HOMER B FOX LE KURZMAN ID
Citation: Jc. Wolf et al., IMMUNOHISTOCHEMICAL DETECTION OF P53 TUMOR-SUPPRESSOR GENE PROTEIN INCANINE EPITHELIAL COLORECTAL TUMORS, Veterinary pathology, 34(5), 1997, pp. 394-404
AMPUTATION AND CARBOPLATIN FOR TREATMENT OF DOGS WITH OSTEOSARCOMA - 48 CASES (1991 TO 1993)
Authors: BERGMAN PJ MACEWEN EG KURZMAN ID HENRY CJ HAMMER AS KNAPP DW HALE A KRUTH SA KLEIN MK KLAUSNER J NORRIS AM MCCAW D STRAW RC WITHROW SJ
Citation: Pj. Bergman et al., AMPUTATION AND CARBOPLATIN FOR TREATMENT OF DOGS WITH OSTEOSARCOMA - 48 CASES (1991 TO 1993), Journal of veterinary internal medicine, 10(2), 1996, pp. 76-81
CANINE OSTEOSARCOMA - AMPUTATION AND CHEMOIMMUNOTHERAPY
Authors: MACEWEN EG KURZMAN ID
Citation: Eg. Macewen et Id. Kurzman, CANINE OSTEOSARCOMA - AMPUTATION AND CHEMOIMMUNOTHERAPY, The Veterinary clinics of North America. Small animal practice, 26(1), 1996, pp. 123
ADJUVANT THERAPY FOR OSTEOSARCOMA IN DOGS - RESULTS OF RANDOMIZED CLINICAL-TRIALS USING COMBINED LIPOSOME-ENCAPSULATED MURAMYL TRIPEPTIDE AND CISPLATIN
Authors: KURZMAN ID MACEWEN EG ROSENTHAL RC FOX LE KELLER ET HELFAND SC VAIL DM DUBIELZIG RR MADEWELL BR RODRIGUEZ CO OBRADOVICH J FIDEL J ROSENBERG M
Citation: Id. Kurzman et al., ADJUVANT THERAPY FOR OSTEOSARCOMA IN DOGS - RESULTS OF RANDOMIZED CLINICAL-TRIALS USING COMBINED LIPOSOME-ENCAPSULATED MURAMYL TRIPEPTIDE AND CISPLATIN, Clinical cancer research, 1(12), 1995, pp. 1595-1601
LIPOSOME-ENCAPSULATED MURAMYL TRIPEPTIDE PHOSPHATIDYLETHANOLAMINE ADJUVANT IMMUNOTHERAPY FOR SPLENIC HEMANGIOSARCOMA IN THE DOG - A RANDOMIZED MULTIINSTITUTIONAL CLINICAL-TRIAL
Authors: VAIL DM MACEWEN EG KURZMAN ID DUBIELZIG RR HELFAND SC KISSEBERTH WC LONDON CA OBRADOVICH JE MADEWELL BR RODRIGUEZ CO FIDEL J SUSANECK S ROSENBERG M
Citation: Dm. Vail et al., LIPOSOME-ENCAPSULATED MURAMYL TRIPEPTIDE PHOSPHATIDYLETHANOLAMINE ADJUVANT IMMUNOTHERAPY FOR SPLENIC HEMANGIOSARCOMA IN THE DOG - A RANDOMIZED MULTIINSTITUTIONAL CLINICAL-TRIAL, Clinical cancer research, 1(10), 1995, pp. 1165-1170
IN-VITRO AND IN-VIVO PRODUCTION OF INTERLEUKIN-6 INDUCED BY MURAMYL PEPTIDES AND LIPOPOLYSACCHARIDE IN NORMAL DOGS
Authors: SHI F KURZMAN ID MACEWEN EG
Citation: F. Shi et al., IN-VITRO AND IN-VIVO PRODUCTION OF INTERLEUKIN-6 INDUCED BY MURAMYL PEPTIDES AND LIPOPOLYSACCHARIDE IN NORMAL DOGS, Cancer biotherapy, 10(4), 1995, pp. 317-325
LIPOSOME-ENCAPSULATED MURAMYL TRIPEPTIDE PHOSPHATIDYLETHANOLAMINE FORTHE TREATMENT OF FELINE MAMMARY ADENOCARCINOMA - A MULTICENTER RANDOMIZED DOUBLE-BLIND-STUDY (VOL 10, PG 125, 1995)
Authors: FOX LE MACEWEN EG KURZMAN ID DUBIELZIG RR HEIFAND SC VAIL DM KISSEBERTH W LONDON C MADEWELL BR RODRIGUEZ CO JEGLUM KA ROSENBERG M ROSENTHAL RC
Citation: Le. Fox et al., LIPOSOME-ENCAPSULATED MURAMYL TRIPEPTIDE PHOSPHATIDYLETHANOLAMINE FORTHE TREATMENT OF FELINE MAMMARY ADENOCARCINOMA - A MULTICENTER RANDOMIZED DOUBLE-BLIND-STUDY (VOL 10, PG 125, 1995), Cancer biotherapy, 10(3), 1995, pp. 249-249
LIPOSOME-ENCAPSULATED MURAMYL TRIPEPTIDE PHOSPHATIDYLETHANOLAMINE FORTHE TREATMENT OF FELINE MAMMARY ADENOCARCINOMA - A MULTICENTER RANDOMIZED DOUBLE-BLIND-STUDY
Authors: FOX LE MACEWEN EG KURZMAN ID DUBIELZIG RR HELFAND SC VAIL DM KISSEBERTH W LONDON C MADEWELL BR RODRIGUEZ CO JEGLUM KA ROSENBERG M ROSENTHAL RC
Citation: Le. Fox et al., LIPOSOME-ENCAPSULATED MURAMYL TRIPEPTIDE PHOSPHATIDYLETHANOLAMINE FORTHE TREATMENT OF FELINE MAMMARY ADENOCARCINOMA - A MULTICENTER RANDOMIZED DOUBLE-BLIND-STUDY, Cancer biotherapy, 10(2), 1995, pp. 125-130
INDUCTION OF SERUM TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-6 ACTIVITY BY LIPOSOME-ENCAPSULATED MURAMYL TRIPEPTIDE-PHOSPHATIDYLETHANOLAMINE (L-MTP-PE) IN NORMAL CATS
Authors: FOX LE KING RR SHI F KURZMAN ID MACEWEN EG KUBILIS PS
Citation: Le. Fox et al., INDUCTION OF SERUM TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-6 ACTIVITY BY LIPOSOME-ENCAPSULATED MURAMYL TRIPEPTIDE-PHOSPHATIDYLETHANOLAMINE (L-MTP-PE) IN NORMAL CATS, Cancer biotherapy, 9(4), 1994, pp. 329-340
EFFECT OF LIPOSOME-MURAMYL TRIPEPTIDE COMBINED WITH RECOMBINANT CANINE GRANULOCYTE-COLONY-STIMULATING FACTOR ON CANINE MONOCYTE ACTIVITY
Authors: KURZMAN ID CHENG HY MACEWEN EG
Citation: Id. Kurzman et al., EFFECT OF LIPOSOME-MURAMYL TRIPEPTIDE COMBINED WITH RECOMBINANT CANINE GRANULOCYTE-COLONY-STIMULATING FACTOR ON CANINE MONOCYTE ACTIVITY, Cancer biotherapy, 9(2), 1994, pp. 113-122
CURRENT STUDIES OF LIPOSOME MURAMYL TRIPEPTIDE (CGP 19835A LIPID) THERAPY FOR METASTASIS IN SPONTANEOUS TUMORS - A PROGRESS REVIEW
Authors: MACEWEN EG KURZMAN ID HELFAND S VAIL D LONDON C KISSEBERTH W ROSENTHAL RC FOX LE KELLER ET OBRADOVICH J MADEWELL B RODRIGUEZ C KITCHELL B FIDEL J SUSANECK S ROSENBERG M
Citation: Eg. Macewen et al., CURRENT STUDIES OF LIPOSOME MURAMYL TRIPEPTIDE (CGP 19835A LIPID) THERAPY FOR METASTASIS IN SPONTANEOUS TUMORS - A PROGRESS REVIEW, Journal of drug targeting., 2(5), 1994, pp. 391-396
PROGNOSTIC FACTORS FOR TREATMENT OF MALIGNANT-LYMPHOMA IN DOGS
Authors: TESKE E VANHEERDE P RUTTEMAN GR KURZMAN ID MOORE PF MACEWEN EG
Citation: E. Teske et al., PROGNOSTIC FACTORS FOR TREATMENT OF MALIGNANT-LYMPHOMA IN DOGS, Journal of the American Veterinary Medical Association, 205(12), 1994, pp. 1722-1728
MURAMYL PEPTIDES AUGMENT THE IN-VITRO AND IN-VIVO CYTOSTATIC ACTIVITYOF CANINE PLASTIC-ADHERENT MONONUCLEAR-CELLS AGAINST CANINE OSTEOSARCOMA CELLS
Authors: SMITH BW KURZMAN ID SCHULTZ KT CZUPRYNSKI CJ MACEWEN EG
Citation: Bw. Smith et al., MURAMYL PEPTIDES AUGMENT THE IN-VITRO AND IN-VIVO CYTOSTATIC ACTIVITYOF CANINE PLASTIC-ADHERENT MONONUCLEAR-CELLS AGAINST CANINE OSTEOSARCOMA CELLS, Cancer biotherapy, 8(2), 1993, pp. 137-144
IN-VITRO AND IN-VIVO CANINE MONONUCLEAR CELL PRODUCTION OF TUMOR-NECROSIS-FACTOR INDUCED BY MURAMYL PEPTIDES AND LIPOPOLYSACCHARIDE
Authors: KURZMAN ID SHI F MACEWEN EG
Citation: Id. Kurzman et al., IN-VITRO AND IN-VIVO CANINE MONONUCLEAR CELL PRODUCTION OF TUMOR-NECROSIS-FACTOR INDUCED BY MURAMYL PEPTIDES AND LIPOPOLYSACCHARIDE, Veterinary immunology and immunopathology, 38(1-2), 1993, pp. 45-56
IN-VITRO AND IN-VIVO EFFECT OF DOXORUBICIN COMBINED WITH LIPOSOME-ENCAPSULATED MURAMYL TRIPEPTIDE ON CANINE MONOCYTE ACTIVATION
Authors: SHI FS MACEWEN EG KURZMAN ID
Citation: Fs. Shi et al., IN-VITRO AND IN-VIVO EFFECT OF DOXORUBICIN COMBINED WITH LIPOSOME-ENCAPSULATED MURAMYL TRIPEPTIDE ON CANINE MONOCYTE ACTIVATION, Cancer research, 53(17), 1993, pp. 3986-3991
Risultati: 1-16 |